Abstract:Background and Purpose: Single Small Subcortical Infarction (SSSI) is a subtype of ischemic stroke with unique pathophysiology, often leading to poor outcomes. This study investigates the association between admission hematocrit (HCT) levels and the risk of progressive stroke in SSSI patients. Methods: We conducted a retrospective cohort study using data from the China National Stroke Registry III, including 2,457 SSSI patients. Progressive stroke was defined as an increase in the NIHSS score by 2 points during hospitalization. Logistic regression models assessed the association between HCT levels and progressive stroke risk. Results: Among 2,457 SSSI patients, 135 (5.50%) experienced progressive stroke. Higher HCT levels were independently associated with a lower risk of progressive stroke (adjusted OR 0.983, 95% CI 0.973-0.994, P = 0.002), with a potential dose-response relationship. The protective effect was more pronounced in patients with severe sensory deficits (P for interaction = 0.013) and younger age (<65 years) (P for interaction = 0.037). Lower HCT levels were also independently associated with increased mortality risk within 3 months after stroke (adjusted OR 0.937, 95% CI 0.892-0.984, P < 0.001). Conclusions: Higher admission HCT levels are associated with a lower risk of progressive stroke in SSSI patients, particularly those with severe sensory deficits and younger age. Lower HCT levels may also increase early mortality risk. These findings highlight the importance of monitoring and optimizing HCT levels in SSSI management. Further research should explore the underlying mechanisms and therapeutic implications ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement non ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: IRB approval number: KY2015-001-01 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data are available upon reasonable request.

Validity of a stroke severity index for administrative claims data research: a retrospective cohort study

Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke

Evaluating the concordance between International Classification of Diseases, Tenth Revision Code and stroke severity as measured by the National Institutes of Health Stroke Scale

Systemic Immune-Inflammation Index and Its Association with the Prevalence of Stroke in the United States Population: A Cross-Sectional Study Using the NHANES Database

Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database

Abstract 5: National Institutes of Health Stroke Scale Reporting in Administrative Claims Data: Incomplete and Biased Reporting in the First Three Years

The Predictive Values of Different Small Vessel Disease Scores on Clinical Outcomes in Mild ICH Patients

Prognostic value of inflammatory markers for in-hospital mortality in intensive care patients with acute ischemic stroke: a retrospective observational study based on MIMIC-IV

Does the Inclusion of Stroke Severity in a 30-Day Mortality Model Change Standardized Mortality Rates at Veterans Affairs Hospitals?

National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years

Persisting Consequences of Stroke Measured by the Stroke Impact Scale

Systemic immune‐inflammation index predicts short‐term mortality in acute ischemic stroke with severe stenosis of internal carotid artery associated pneumonia

Change in Hospital Risk-standardized Stroke Mortality Performance With and Without the Passive Surveillance Stroke Severity Score

Validation of the Machine Learning–Based Stroke Impact Scale With a Cross-Cultural Sample

Development and Validation of a Novel Score for Predicting Long-Term Mortality after an Acute Ischemic Stroke

Abstract WP184: Identifying Optimal Cut Points Of National Institutes Of Health Stroke Scale To Predict Mortality: A Population-based Assessment

The National Institutes of Health Stroke Scale is comparable to the ICH score in predicting outcomes in spontaneous acute intracerebral hemorrhage

Systemic Immune-Inflammation Index (SII) but Not Platelet-Albumin-bilirubin (PALBI) Grade is Associated with Severity of Acute Ischemic Stroke (AIS)

Research on Validity Evaluation of Chinese Version of Stroke Impact Scale

Predicting Poststroke Cognitive Impairment after Acute Ischemic Stroke Based on Admission Characteristics

Hematocrit and Progressive Stroke in Single Small Subcortical Infarction: Insights from the China Stroke Registry III